FATE
Fate Therapeutics Inc.
$2.15
-$0.10(-4.44%)
61
Overall
60
Value
81
Tech
42
Quality
Market Cap
$137.24M
Volume
5.57M
52W Range
$0.91 - $2.47
Target Price
$5.30
EPS Estimates Overview
| Current Quarter | $-0.29 | Next Quarter | $-0.29 |
| Current Year | $-1.07 | Next Year | $-0.99 |
| QoQ Growth | +0.0% | YoY Growth | +7.5% |
| 3Y EPS CAGR | +26.6% | Target Price | $5.30 |
| Consensus | Buy | Upside | +146.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $2.15 | -4.4% | 5.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |